Lumos Pharma Inc (LUMO)
2.286
+0.03
(+1.55%)
USD |
NASDAQ |
Jun 28, 16:00
2.25
-0.04
(-1.57%)
After-Hours: 20:00
Lumos Pharma Cash from Financing (Quarterly): -0.005M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.005M |
| December 31, 2023 | 0.742M |
| September 30, 2023 | -0.435M |
| June 30, 2023 | -0.574M |
| March 31, 2023 | -0.309M |
| December 31, 2022 | -0.475M |
| September 30, 2022 | -0.326M |
| June 30, 2022 | -0.002M |
| March 31, 2022 | -0.018M |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.026M |
| March 31, 2021 | -0.166M |
| December 31, 2020 | 0.096M |
| September 30, 2020 | -0.011M |
| June 30, 2020 | -0.01M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.022M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | |
| December 31, 2018 | -0.012M |
| September 30, 2018 | -0.005M |
| June 30, 2018 | 0.093M |
| March 31, 2018 | -0.224M |
| Date | Value |
|---|---|
| December 31, 2017 | 55.15M |
| September 30, 2017 | 20.05M |
| June 30, 2017 | 0.314M |
| March 31, 2017 | -0.228M |
| December 31, 2016 | 0.405M |
| September 30, 2016 | 1.052M |
| June 30, 2016 | 0.455M |
| March 31, 2016 | -0.029M |
| December 31, 2015 | 6.34M |
| September 30, 2015 | 1.079M |
| June 30, 2015 | 1.041M |
| March 31, 2015 | 14.62M |
| December 31, 2014 | 4.77M |
| September 30, 2014 | 0.149M |
| June 30, 2014 | 0.388M |
| March 31, 2014 | 28.58M |
| December 31, 2013 | 17.74M |
| September 30, 2013 | -0.039M |
| June 30, 2013 | 0.329M |
| March 31, 2013 | 48.97M |
| December 31, 2012 | 0.295M |
| September 30, 2012 | 0.606M |
| June 30, 2012 | 0.529M |
| March 31, 2012 | 0.078M |
| December 31, 2011 | 37.50M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.574M
Minimum
Jun 2023
0.742M
Maximum
Dec 2023
-0.0748M
Average
-0.0075M
Median
Cash from Financing (Quarterly) Benchmarks
| icad Inc | -- |
| Perspective Therapeutics Inc | 166.33M |
| Palatin Technologies Inc | 9.136M |
| Bio-Path Holdings Inc | 0.174M |
| PDS Biotechnology Corp | 20.01M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.89M |
| Cash from Investing (Quarterly) | 1.00M |
| Free Cash Flow | -34.79M |
| Free Cash Flow Per Share (Quarterly) | -1.591 |
| Free Cash Flow to Equity (Quarterly) | -12.89M |
| Free Cash Flow Yield | -188.0% |